z-logo
open-access-imgOpen Access
Lurasidone: new development for the treatment of psychosis
Author(s) -
Stokes Paul,
Young Allan
Publication year - 2013
Publication title -
future prescriber
Language(s) - English
Resource type - Journals
eISSN - 1931-2261
pISSN - 1468-9871
DOI - 10.1002/fps.106
Subject(s) - lurasidone , bipolar disorder , mania , schizophrenia (object oriented programming) , psychosis , medicine , psychiatry , treatment of bipolar disorder , safety profile , bipolar i disorder , antipsychotic , pharmacology , adverse effect , mood
Although we have had efficacious medications for both schizophrenia and bipolar disorder for over half a century, there remains a clear need for more effective and better‐tolerated treatments for both conditions. Current antipsychotics often have troubling side‐effect profiles particularly with respect to weight gain and cardiometabolic parameters. These drawbacks also extend to treatment of mania and there are very few evidence‐based treatments for the depressed phases of bipolar disorder. The introduction of a novel treatment with a potentially better risk‐to‐benefit profile is therefore welcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here